Study Yields Promising Results For Treating Triple-Negative Breast Cancer

Faith Castro
October 23, 2018

Because of charities like Hail's, there are now ways for everyone to become more informed and educated on diseases such as breast cancer. From Becca's iconic Opal highlighter to Elemis's cult-classic cleansing balm, there's a BCA beauty item that will check a box off your shopping list.

Women in the study who received Tecentriq plus chemo went two months longer on average without their cancer worsening compared with those on chemo alone - a modest benefit.

Breast cancer is the most commonly diagnosed cancer among women in Taiwan, with about 10,000 new cases reported each year, HPA statistics show. That means hormone therapy won't work against TNBC and neither will drugs that target HER2. "In addition, young women cannot smoke, try to keep their weight within a normal BMI limit, do self breast exams and see primary caregivers for a physical every year so that they can have a clinical breast exam".

The results were announced at the ESMO congress, where on Saturday Roche also announced positive results from a study of Tecentriq plus chemotherapy for the first-line treatment of unresectable locally advanced or metastatic triple-negative breast cancer (TNBC).

More news: Trump administration could rollback transgender protections and initiatives from Obama era

A former member of the Japanese idol group SKE48 who recently had breast cancer surgery is urging women to have regular checkups for the disease.

The Knoxville Post Office, located at 1237 East Weisgarber Road, will host an event to promote breast cancer awareness and celebrate the success of the first semipostal stamp, the Breast Cancer Research Stamp. The study included 902 patients treated at 246 medical centers in 41 countries. "The hope is that breast cancer screening guidelines might change based on our findings", Couch says. "It is an illustration too of the way that targeted drugs can be given together in innovative combinations, as a way of tackling cancer's ability to adapt and evolve, and slowing down development of resistance to treatment". "Because I know that the triple negative is a type of cancer that is really hard to treat".

"We couldn't do it without our caregivers and our spouses and I was very blessed", Hoskins said. But what they didn't show may be just as important, one executive figures. "Lung cancer is a complex disease and this combination could offer a new potential treatment option". The researchers also boasted that the new treatment can reduce the risk of dying of cancer by 40 percent. "This is the result of our strong, 15-year partnership with the Professionals and is a reflection of your passion and dedication to helping NBCF fund world-class breast cancer research", she said.

Other reports by LeisureTravelAid

Discuss This Article

FOLLOW OUR NEWSPAPER